These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22425565)

  • 1. Footprint-based identification of viral entry inhibitors targeting HIVgp41.
    Holden PM; Kaur H; Goyal R; Gochin M; Rizzo RC
    Bioorg Med Chem Lett; 2012 Apr; 22(8):3011-6. PubMed ID: 22425565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based identification of inhibitors targeting obstruction of the HIVgp41 N-heptad repeat trimer.
    McGee TD; Yi HA; Allen WJ; Jacobs A; Rizzo RC
    Bioorg Med Chem Lett; 2017 Jul; 27(14):3177-3184. PubMed ID: 28558972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule inhibitors of HIVgp41 N-heptad repeat trimer formation.
    Allen WJ; Yi HA; Gochin M; Jacobs A; Rizzo RC
    Bioorg Med Chem Lett; 2015 Jul; 25(14):2853-9. PubMed ID: 26013847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for lead discovery: application of footprint similarity targeting HIVgp41.
    Holden PM; Allen WJ; Gochin M; Rizzo RC
    Bioorg Med Chem; 2014 Jan; 22(1):651-61. PubMed ID: 24315195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Origins of resistance to the HIVgp41 viral entry inhibitor T20.
    McGillick BE; Balius TE; Mukherjee S; Rizzo RC
    Biochemistry; 2010 May; 49(17):3575-92. PubMed ID: 20230061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemistry and biophysics of HIV-1 gp41 - membrane interactions and implications for HIV-1 envelope protein mediated viral-cell fusion and fusion inhibitor design.
    Cai L; Gochin M; Liu K
    Curr Top Med Chem; 2011 Dec; 11(24):2959-84. PubMed ID: 22044229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of HIV-1 inhibitory peptide T20 with the gp41 N-HR coiled coil.
    Champagne K; Shishido A; Root MJ
    J Biol Chem; 2009 Feb; 284(6):3619-27. PubMed ID: 19073602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of a subpocket on the N-trimer of HIV-1 Gp41: implication for viral entry and drug target.
    Qiu Z; Chong H; Yao X; Su Y; Cui S; He Y
    AIDS; 2015 Jun; 29(9):1015-24. PubMed ID: 26125136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches for identification of HIV-1 entry inhibitors targeting gp41 pocket.
    Yu F; Lu L; Du L; Zhu X; Debnath AK; Jiang S
    Viruses; 2013 Jan; 5(1):127-49. PubMed ID: 23344560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the sticky fingers of HIV-1.
    Blumenthal R; Dimitrov DS
    Cell; 2007 Apr; 129(2):243-5. PubMed ID: 17448985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.
    Su S; Zhu Y; Ye S; Qi Q; Xia S; Ma Z; Yu F; Wang Q; Zhang R; Jiang S; Lu L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and evaluation of indole compounds as novel inhibitors targeting Gp41.
    Zhou G; Wu D; Hermel E; Balogh E; Gochin M
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1500-3. PubMed ID: 20153190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A low-molecular-weight entry inhibitor of both CCR5- and CXCR4-tropic strains of human immunodeficiency virus type 1 targets a novel site on gp41.
    Murray EJ; Leaman DP; Pawa N; Perkins H; Pickford C; Perros M; Zwick MB; Butler SL
    J Virol; 2010 Jul; 84(14):7288-99. PubMed ID: 20427524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-molecule HIV-1 entry inhibitors targeting gp120 and gp41: a patent review (2010-2015).
    Li W; Lu L; Li W; Jiang S
    Expert Opin Ther Pat; 2017 Jun; 27(6):707-719. PubMed ID: 28076686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide and non-peptide HIV fusion inhibitors.
    Jiang S; Zhao Q; Debnath AK
    Curr Pharm Des; 2002; 8(8):563-80. PubMed ID: 11945159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of N-carboxyphenylpyrrole derivatives as potent HIV fusion inhibitors targeting gp41.
    Liu K; Lu H; Hou L; Qi Z; Teixeira C; Barbault F; Fan BT; Liu S; Jiang S; Xie L
    J Med Chem; 2008 Dec; 51(24):7843-54. PubMed ID: 19053778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential HIV-1 fusion inhibitors mimicking gp41-specific broadly neutralizing antibody 10E8: In silico discovery and prediction of antiviral potency.
    Andrianov AM; Kashyn IA; Tuzikov AV
    J Bioinform Comput Biol; 2018 Apr; 16(2):1840007. PubMed ID: 29439644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Entry Inhibitors: A Review of Experimental and Computational Studies.
    Mostashari Rad T; Saghaie L; Fassihi A
    Chem Biodivers; 2018 Oct; 15(10):e1800159. PubMed ID: 30027572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.
    Münch J; Ständker L; Adermann K; Schulz A; Schindler M; Chinnadurai R; Pöhlmann S; Chaipan C; Biet T; Peters T; Meyer B; Wilhelm D; Lu H; Jing W; Jiang S; Forssmann WG; Kirchhoff F
    Cell; 2007 Apr; 129(2):263-75. PubMed ID: 17448989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of critical residues for viral entry and inhibition through structural Insight of HIV-1 fusion inhibitor CP621-652.
    Chong H; Yao X; Qiu Z; Qin B; Han R; Waltersperger S; Wang M; Cui S; He Y
    J Biol Chem; 2012 Jun; 287(24):20281-9. PubMed ID: 22511760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.